The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intravenous Immune Globulin Therapies Market Research Report 2025
Synopsis
Immune globulin derived from the plasma of paid and volunteer donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders.
The global Intravenous Immune Globulin Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Intravenous Immune Globulin Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intravenous Immune Globulin Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Intravenous Immune Globulin Therapies in Immunodeficiency is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Intravenous Immune Globulin Therapies include Baxter, Grifols, CSL Plasma, Octapharma, Biotest, Kedrion, Kamada, China Biologic Products Holdings and Hualan Biological Engineering, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Intravenous Immune Globulin Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Immune Globulin Therapies.
Report Scope
The Intravenous Immune Globulin Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Immune Globulin Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Immune Globulin Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Grifols
CSL Plasma
Octapharma
Biotest
Kedrion
Kamada
China Biologic Products Holdings
Hualan Biological Engineering
Sichuan Yuanda Shuyang Pharmaceutical
Segment by Type
Liquid Form
Lyophilized Powder Form
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravenous Immune Globulin Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Immune globulin derived from the plasma of paid and volunteer donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders.
The global Intravenous Immune Globulin Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Intravenous Immune Globulin Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intravenous Immune Globulin Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Intravenous Immune Globulin Therapies in Immunodeficiency is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Intravenous Immune Globulin Therapies include Baxter, Grifols, CSL Plasma, Octapharma, Biotest, Kedrion, Kamada, China Biologic Products Holdings and Hualan Biological Engineering, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Intravenous Immune Globulin Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Immune Globulin Therapies.
Report Scope
The Intravenous Immune Globulin Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Immune Globulin Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Immune Globulin Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Grifols
CSL Plasma
Octapharma
Biotest
Kedrion
Kamada
China Biologic Products Holdings
Hualan Biological Engineering
Sichuan Yuanda Shuyang Pharmaceutical
Segment by Type
Liquid Form
Lyophilized Powder Form
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravenous Immune Globulin Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liquid Form
1.2.3 Lyophilized Powder Form
1.3 Market by Application
1.3.1 Global Intravenous Immune Globulin Therapies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intravenous Immune Globulin Therapies Market Perspective (2019-2030)
2.2 Intravenous Immune Globulin Therapies Growth Trends by Region
2.2.1 Global Intravenous Immune Globulin Therapies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Intravenous Immune Globulin Therapies Historic Market Size by Region (2019-2024)
2.2.3 Intravenous Immune Globulin Therapies Forecasted Market Size by Region (2025-2030)
2.3 Intravenous Immune Globulin Therapies Market Dynamics
2.3.1 Intravenous Immune Globulin Therapies Industry Trends
2.3.2 Intravenous Immune Globulin Therapies Market Drivers
2.3.3 Intravenous Immune Globulin Therapies Market Challenges
2.3.4 Intravenous Immune Globulin Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intravenous Immune Globulin Therapies Players by Revenue
3.1.1 Global Top Intravenous Immune Globulin Therapies Players by Revenue (2019-2024)
3.1.2 Global Intravenous Immune Globulin Therapies Revenue Market Share by Players (2019-2024)
3.2 Global Intravenous Immune Globulin Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intravenous Immune Globulin Therapies Revenue
3.4 Global Intravenous Immune Globulin Therapies Market Concentration Ratio
3.4.1 Global Intravenous Immune Globulin Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intravenous Immune Globulin Therapies Revenue in 2023
3.5 Intravenous Immune Globulin Therapies Key Players Head office and Area Served
3.6 Key Players Intravenous Immune Globulin Therapies Product Solution and Service
3.7 Date of Enter into Intravenous Immune Globulin Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intravenous Immune Globulin Therapies Breakdown Data by Type
4.1 Global Intravenous Immune Globulin Therapies Historic Market Size by Type (2019-2024)
4.2 Global Intravenous Immune Globulin Therapies Forecasted Market Size by Type (2025-2030)
5 Intravenous Immune Globulin Therapies Breakdown Data by Application
5.1 Global Intravenous Immune Globulin Therapies Historic Market Size by Application (2019-2024)
5.2 Global Intravenous Immune Globulin Therapies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Intravenous Immune Globulin Therapies Market Size (2019-2030)
6.2 North America Intravenous Immune Globulin Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Intravenous Immune Globulin Therapies Market Size by Country (2019-2024)
6.4 North America Intravenous Immune Globulin Therapies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intravenous Immune Globulin Therapies Market Size (2019-2030)
7.2 Europe Intravenous Immune Globulin Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Intravenous Immune Globulin Therapies Market Size by Country (2019-2024)
7.4 Europe Intravenous Immune Globulin Therapies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intravenous Immune Globulin Therapies Market Size (2019-2030)
8.2 Asia-Pacific Intravenous Immune Globulin Therapies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Intravenous Immune Globulin Therapies Market Size by Region (2019-2024)
8.4 Asia-Pacific Intravenous Immune Globulin Therapies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intravenous Immune Globulin Therapies Market Size (2019-2030)
9.2 Latin America Intravenous Immune Globulin Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Intravenous Immune Globulin Therapies Market Size by Country (2019-2024)
9.4 Latin America Intravenous Immune Globulin Therapies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intravenous Immune Globulin Therapies Market Size (2019-2030)
10.2 Middle East & Africa Intravenous Immune Globulin Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Country (2019-2024)
10.4 Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Detail
11.1.2 Baxter Business Overview
11.1.3 Baxter Intravenous Immune Globulin Therapies Introduction
11.1.4 Baxter Revenue in Intravenous Immune Globulin Therapies Business (2019-2024)
11.1.5 Baxter Recent Development
11.2 Grifols
11.2.1 Grifols Company Detail
11.2.2 Grifols Business Overview
11.2.3 Grifols Intravenous Immune Globulin Therapies Introduction
11.2.4 Grifols Revenue in Intravenous Immune Globulin Therapies Business (2019-2024)
11.2.5 Grifols Recent Development
11.3 CSL Plasma
11.3.1 CSL Plasma Company Detail
11.3.2 CSL Plasma Business Overview
11.3.3 CSL Plasma Intravenous Immune Globulin Therapies Introduction
11.3.4 CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2019-2024)
11.3.5 CSL Plasma Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Detail
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Intravenous Immune Globulin Therapies Introduction
11.4.4 Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2019-2024)
11.4.5 Octapharma Recent Development
11.5 Biotest
11.5.1 Biotest Company Detail
11.5.2 Biotest Business Overview
11.5.3 Biotest Intravenous Immune Globulin Therapies Introduction
11.5.4 Biotest Revenue in Intravenous Immune Globulin Therapies Business (2019-2024)
11.5.5 Biotest Recent Development
11.6 Kedrion
11.6.1 Kedrion Company Detail
11.6.2 Kedrion Business Overview
11.6.3 Kedrion Intravenous Immune Globulin Therapies Introduction
11.6.4 Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2019-2024)
11.6.5 Kedrion Recent Development
11.7 Kamada
11.7.1 Kamada Company Detail
11.7.2 Kamada Business Overview
11.7.3 Kamada Intravenous Immune Globulin Therapies Introduction
11.7.4 Kamada Revenue in Intravenous Immune Globulin Therapies Business (2019-2024)
11.7.5 Kamada Recent Development
11.8 China Biologic Products Holdings
11.8.1 China Biologic Products Holdings Company Detail
11.8.2 China Biologic Products Holdings Business Overview
11.8.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Introduction
11.8.4 China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2019-2024)
11.8.5 China Biologic Products Holdings Recent Development
11.9 Hualan Biological Engineering
11.9.1 Hualan Biological Engineering Company Detail
11.9.2 Hualan Biological Engineering Business Overview
11.9.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Introduction
11.9.4 Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2019-2024)
11.9.5 Hualan Biological Engineering Recent Development
11.10 Sichuan Yuanda Shuyang Pharmaceutical
11.10.1 Sichuan Yuanda Shuyang Pharmaceutical Company Detail
11.10.2 Sichuan Yuanda Shuyang Pharmaceutical Business Overview
11.10.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Introduction
11.10.4 Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2019-2024)
11.10.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Liquid Form
Table 3. Key Players of Lyophilized Powder Form
Table 4. Global Intravenous Immune Globulin Therapies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Intravenous Immune Globulin Therapies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Intravenous Immune Globulin Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Intravenous Immune Globulin Therapies Market Share by Region (2019-2024)
Table 8. Global Intravenous Immune Globulin Therapies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Intravenous Immune Globulin Therapies Market Share by Region (2025-2030)
Table 10. Intravenous Immune Globulin Therapies Market Trends
Table 11. Intravenous Immune Globulin Therapies Market Drivers
Table 12. Intravenous Immune Globulin Therapies Market Challenges
Table 13. Intravenous Immune Globulin Therapies Market Restraints
Table 14. Global Intravenous Immune Globulin Therapies Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Intravenous Immune Globulin Therapies Market Share by Players (2019-2024)
Table 16. Global Top Intravenous Immune Globulin Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immune Globulin Therapies as of 2023)
Table 17. Ranking of Global Top Intravenous Immune Globulin Therapies Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Intravenous Immune Globulin Therapies Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Intravenous Immune Globulin Therapies Product Solution and Service
Table 21. Date of Enter into Intravenous Immune Globulin Therapies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Intravenous Immune Globulin Therapies Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Intravenous Immune Globulin Therapies Revenue Market Share by Type (2019-2024)
Table 25. Global Intravenous Immune Globulin Therapies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Intravenous Immune Globulin Therapies Revenue Market Share by Type (2025-2030)
Table 27. Global Intravenous Immune Globulin Therapies Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Intravenous Immune Globulin Therapies Revenue Market Share by Application (2019-2024)
Table 29. Global Intravenous Immune Globulin Therapies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Intravenous Immune Globulin Therapies Revenue Market Share by Application (2025-2030)
Table 31. North America Intravenous Immune Globulin Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Intravenous Immune Globulin Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Intravenous Immune Globulin Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Intravenous Immune Globulin Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Intravenous Immune Globulin Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Intravenous Immune Globulin Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Intravenous Immune Globulin Therapies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Intravenous Immune Globulin Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Intravenous Immune Globulin Therapies Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Intravenous Immune Globulin Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Intravenous Immune Globulin Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Intravenous Immune Globulin Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Intravenous Immune Globulin Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 46. Baxter Company Detail
Table 47. Baxter Business Overview
Table 48. Baxter Intravenous Immune Globulin Therapies Product
Table 49. Baxter Revenue in Intravenous Immune Globulin Therapies Business (2019-2024) & (US$ Million)
Table 50. Baxter Recent Development
Table 51. Grifols Company Detail
Table 52. Grifols Business Overview
Table 53. Grifols Intravenous Immune Globulin Therapies Product
Table 54. Grifols Revenue in Intravenous Immune Globulin Therapies Business (2019-2024) & (US$ Million)
Table 55. Grifols Recent Development
Table 56. CSL Plasma Company Detail
Table 57. CSL Plasma Business Overview
Table 58. CSL Plasma Intravenous Immune Globulin Therapies Product
Table 59. CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2019-2024) & (US$ Million)
Table 60. CSL Plasma Recent Development
Table 61. Octapharma Company Detail
Table 62. Octapharma Business Overview
Table 63. Octapharma Intravenous Immune Globulin Therapies Product
Table 64. Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2019-2024) & (US$ Million)
Table 65. Octapharma Recent Development
Table 66. Biotest Company Detail
Table 67. Biotest Business Overview
Table 68. Biotest Intravenous Immune Globulin Therapies Product
Table 69. Biotest Revenue in Intravenous Immune Globulin Therapies Business (2019-2024) & (US$ Million)
Table 70. Biotest Recent Development
Table 71. Kedrion Company Detail
Table 72. Kedrion Business Overview
Table 73. Kedrion Intravenous Immune Globulin Therapies Product
Table 74. Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2019-2024) & (US$ Million)
Table 75. Kedrion Recent Development
Table 76. Kamada Company Detail
Table 77. Kamada Business Overview
Table 78. Kamada Intravenous Immune Globulin Therapies Product
Table 79. Kamada Revenue in Intravenous Immune Globulin Therapies Business (2019-2024) & (US$ Million)
Table 80. Kamada Recent Development
Table 81. China Biologic Products Holdings Company Detail
Table 82. China Biologic Products Holdings Business Overview
Table 83. China Biologic Products Holdings Intravenous Immune Globulin Therapies Product
Table 84. China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2019-2024) & (US$ Million)
Table 85. China Biologic Products Holdings Recent Development
Table 86. Hualan Biological Engineering Company Detail
Table 87. Hualan Biological Engineering Business Overview
Table 88. Hualan Biological Engineering Intravenous Immune Globulin Therapies Product
Table 89. Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2019-2024) & (US$ Million)
Table 90. Hualan Biological Engineering Recent Development
Table 91. Sichuan Yuanda Shuyang Pharmaceutical Company Detail
Table 92. Sichuan Yuanda Shuyang Pharmaceutical Business Overview
Table 93. Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Product
Table 94. Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2019-2024) & (US$ Million)
Table 95. Sichuan Yuanda Shuyang Pharmaceutical Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intravenous Immune Globulin Therapies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Intravenous Immune Globulin Therapies Market Share by Type: 2023 VS 2030
Figure 3. Liquid Form Features
Figure 4. Lyophilized Powder Form Features
Figure 5. Global Intravenous Immune Globulin Therapies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Intravenous Immune Globulin Therapies Market Share by Application: 2023 VS 2030
Figure 7. Immunodeficiency Case Studies
Figure 8. Autoimmune Disease Case Studies
Figure 9. Acute Infection Case Studies
Figure 10. Intravenous Immune Globulin Therapies Report Years Considered
Figure 11. Global Intravenous Immune Globulin Therapies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Intravenous Immune Globulin Therapies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Intravenous Immune Globulin Therapies Market Share by Region: 2023 VS 2030
Figure 14. Global Intravenous Immune Globulin Therapies Market Share by Players in 2023
Figure 15. Global Top Intravenous Immune Globulin Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immune Globulin Therapies as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Intravenous Immune Globulin Therapies Revenue in 2023
Figure 17. North America Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Intravenous Immune Globulin Therapies Market Share by Country (2019-2030)
Figure 19. United States Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Intravenous Immune Globulin Therapies Market Share by Country (2019-2030)
Figure 23. Germany Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Intravenous Immune Globulin Therapies Market Share by Region (2019-2030)
Figure 31. China Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Intravenous Immune Globulin Therapies Market Share by Country (2019-2030)
Figure 39. Mexico Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Intravenous Immune Globulin Therapies Market Share by Country (2019-2030)
Figure 43. Turkey Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Intravenous Immune Globulin Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Baxter Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2019-2024)
Figure 46. Grifols Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2019-2024)
Figure 47. CSL Plasma Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2019-2024)
Figure 48. Octapharma Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2019-2024)
Figure 49. Biotest Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2019-2024)
Figure 50. Kedrion Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2019-2024)
Figure 51. Kamada Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2019-2024)
Figure 52. China Biologic Products Holdings Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2019-2024)
Figure 53. Hualan Biological Engineering Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2019-2024)
Figure 54. Sichuan Yuanda Shuyang Pharmaceutical Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
